Sutro Biopharma Inc (STRO)
2.51
-0.02
(-0.79%)
USD |
NASDAQ |
Nov 22, 16:00
2.52
+0.01
(+0.40%)
After-Hours: 20:00
Sutro Biopharma Debt to Equity Ratio: 0.00 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.0271 |
| September 30, 2023 | 0.0635 |
| June 30, 2023 | 0.0659 |
| March 31, 2023 | 0.0714 |
| December 31, 2022 | 0.075 |
| September 30, 2022 | 0.0839 |
| June 30, 2022 | 0.1066 |
| March 31, 2022 | 0.1146 |
| December 31, 2021 | 0.0994 |
| September 30, 2021 | 0.088 |
| June 30, 2021 | 0.0807 |
| Date | Value |
|---|---|
| March 31, 2021 | 0.0803 |
| December 31, 2020 | 0.0739 |
| September 30, 2020 | 0.10 |
| June 30, 2020 | 0.1174 |
| March 31, 2020 | 0.2943 |
| December 31, 2019 | 0.101 |
| September 30, 2019 | 0.1032 |
| June 30, 2019 | 0.1071 |
| March 31, 2019 | 0.1091 |
| December 31, 2018 | 0.1119 |
| September 30, 2018 | -0.1038 |
| June 30, 2018 | -0.1121 |
| March 31, 2018 | |
| December 31, 2017 | -0.1336 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Mar 2024
0.2943
Maximum
Mar 2020
0.0821
Average
0.0805
Median
Debt to Equity Ratio Benchmarks
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 451.83M |
| Total Liabilities (Quarterly) | 340.61M |
| Shareholders Equity (Quarterly) | 111.22M |
| Current Ratio | 3.091 |
| Net Debt Paydown Yield | 0.72% |